In a sensitivity analysis, based on the findings of Pashayan et al (2006), we estimated the expected number of men in England undertaking PSA testing and the proportion of the prostate cancer diagnosis following PSA testing. The gene discussed is KLK3; the disease is Familial prostate cancer.